Lenalidomide 10mg Capsule

Lenalidomide 10mg Capsule contains lenalidomide, an oral immunomodulatory anticancer medicine used in approved treatment protocols for multiple myeloma, myelodysplastic syndromes and selected lymphomas, depending on the country-specific label. Generic lenalidomide 10mg is available from multiple manufacturers as an alternative to Revlimid® 10mg. International search terminology includes Lenalidomid 10 mg Hartkapseln, lénalidomide 10 mg, 레날리도마이드 10mg and леналидомид 10 мг.

Product Information

Generic Name

Lenalidomide

Strength

10mg

Dosage Form

Hard Capsule

Route

Oral

Drug Class

Immunomodulatory Antineoplastic Agent

Reference Brand

Revlimid® 10mg

Main Therapeutic Area

Hematologic Oncology

Prescription Status

Prescription medicine

Manufacturer

Varies by product

Pack Size

Varies by market and manufacturer

Generic Revlimid® 10mg

Revlimid® is the reference medicine containing lenalidomide. Generic products contain lenalidomide as the active ingredient but may differ in manufacturer, capsule appearance, inactive ingredients and packaging.

France's public medicines database explicitly identifies Lenalidomide Accord 10mg as a generic equivalent to Revlimid 10mg, with multiple additional generic products listed in the same 10mg group.

Commercial Availability

High-intent searches include lenalidomide 10mg price, lenalidomide 10mg capsule, generic Revlimid 10mg, Revlimid 10mg capsule, lenalidomide 10mg pharmacy, lenalidomide 10mg 21 capsules and lenalidomide 10mg cost. The exact product supplied should match the manufacturer's approved presentation and the prescription/import rules of the destination market.

Lenalidomide 10mg is used in approved treatment regimens for multiple myeloma and certain myelodysplastic syndromes and lymphomas, with the exact indications depending on the national product authorization. Current UK product information includes multiple myeloma, transfusion-dependent low/intermediate-1-risk MDS with isolated deletion 5q, relapsed/refractory mantle cell lymphoma and previously treated follicular lymphoma.

Lenalidomide is a high-risk prescription oncology medicine. Important safety concerns include embryo-fetal toxicity, neutropenia, thrombocytopenia and thromboembolic events. U.S. supply is subject to the Lenalidomide REMS program. Capsules should be swallowed whole and not opened, broken or chewed.